AtriCure, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
AtriCure, Inc. (ATRC) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of -$5.10 million for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2021-08-05
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2021-06-30 was -$2.60M, a 134.65% decline year-over-year.
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2021-03-31 was -$2.50M.
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2020-12-31 was -$4.50M.
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2020-09-30 was -$192.00K, a 106.27% decline year-over-year.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month |
|---|---|---|---|---|
| 2021-06-30 | -$2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$5.10M 10-Q · filed 2021-08-05 | -$9.60M derived: sum of 3 quarters · filed 2021-08-05 | -$9.79M derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | -$2.50M 10-Q · filed 2021-04-28 | -$7.00M derived: sum of 2 quarters · filed 2021-08-05 | -$7.19M derived: sum of 3 quarters · filed 2021-08-05 | $315.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-12-31 | -$4.50M derived: 10-Q 12 month − 10-Q 9 month · filed 2021-08-05 | -$4.69M derived: sum of 2 quarters · filed 2021-08-05 | $2.81M derived: sum of 3 quarters · filed 2021-08-05 | $357.00K 10-Q · filed 2021-08-05 |
| 2020-09-30 | -$192.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $7.31M derived: sum of 2 quarters · filed 2020-11-06 | $4.85M 10-Q · filed 2020-11-06 | $2.84M derived: sum of 4 quarters · filed 2020-11-06 |
| 2020-06-30 | $7.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $5.05M 10-Q · filed 2020-07-29 | $3.03M derived: sum of 3 quarters · filed 2020-11-06 | $6.09M derived: sum of 4 quarters · filed 2020-11-06 |
| 2020-03-31 | -$2.46M 10-Q · filed 2020-04-30 | -$4.48M derived: sum of 2 quarters · filed 2020-11-06 | -$1.41M derived: sum of 3 quarters · filed 2020-11-06 | $791.00K derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-12-31 | -$2.02M derived: 10-Q 12 month − 10-Q 9 month · filed 2020-11-06 | $1.04M derived: sum of 2 quarters · filed 2020-11-06 | $3.25M derived: sum of 3 quarters · filed 2020-11-06 | $4.92M 10-Q · filed 2020-11-06 |
| 2019-09-30 | $3.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $5.27M derived: sum of 2 quarters · filed 2019-10-31 | $6.93M 10-Q · filed 2019-10-31 | $11.06M derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-06-30 | $2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $3.87M 10-Q · filed 2019-07-31 | $8.00M derived: sum of 3 quarters · filed 2019-10-31 | $8.78M derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-03-31 | $1.67M 10-Q · filed 2019-04-26 | $5.80M derived: sum of 2 quarters · filed 2019-10-31 | $6.58M derived: sum of 3 quarters · filed 2019-10-31 | |
| 2018-12-31 | $4.13M derived: 10-Q 12 month − 10-Q 9 month · filed 2019-10-31 | $4.91M derived: sum of 2 quarters · filed 2019-10-31 | $10.82M 10-Q · filed 2019-10-31 | |
| 2018-09-30 | $780.00K 10-Q · filed 2018-11-02 | $6.70M 10-Q · filed 2018-11-02 | ||
| 2018-06-30 | $5.92M 10-Q · filed 2018-08-02 | |||
| 2017-12-31 | $4.08M 10-Q · filed 2018-11-02 | |||
| 2014-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2015-07-31 | -$5.37M derived: sum of 2 quarters · filed 2015-07-31 | -$8.03M 10-Q · filed 2015-07-31 | |
| 2014-09-30 | -$5.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | -$8.03M 10-Q · filed 2014-10-31 | ||
| 2014-06-30 | -$2.66M 10-Q · filed 2014-07-30 | |||
| 2013-12-31 | $0.00 10-Q · filed 2014-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |